0001209191-23-026798.txt : 20230503 0001209191-23-026798.hdr.sgml : 20230503 20230503084007 ACCESSION NUMBER: 0001209191-23-026798 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bolte Axel CENTRAL INDEX KEY: 0001579247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39397 FILM NUMBER: 23881875 MAIL ADDRESS: STREET 1: PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inozyme Pharma, Inc. CENTRAL INDEX KEY: 0001693011 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475129768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 SUMMER STREET STREET 2: SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-330-4340 MAIL ADDRESS: STREET 1: 321 SUMMER STREET STREET 2: SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Inozyme Pharma, LLC DATE OF NAME CHANGE: 20161222 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-01 0 0001693011 Inozyme Pharma, Inc. INZY 0001579247 Bolte Axel C/O INOZYME PHARMA, INC. 321 SUMMER STREET SUITE 400 BOSTON MA 02210 1 0 0 0 0 Stock option (right to buy) 5.81 2023-05-01 4 A 0 100000 0.00 A 2033-04-30 Common Stock 100000 100000 D The option was granted on May 1, 2023. The shares underlying the option are scheduled to vest in equal monthly installments from June 1, 2023 through May 1, 2025, provided Mr. Bolte is providing services to the Company on such dates. /s/ Sanjay Subramanian, as attorney-in-fact for Axel Bolte 2023-05-03